Trial Profile
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs AI 401 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TN07
- 08 Feb 2019 Canada was a planned location according to European Clinical Trials Database.
- 08 Feb 2019 Status changed from active, no longer recruiting to completed.
- 08 Feb 2019 This trial has been completed in United Kingdom, as reported by European Clinical Trials Database record.